0001415889-24-002729.txt : 20240205
0001415889-24-002729.hdr.sgml : 20240205
20240205191836
ACCESSION NUMBER: 0001415889-24-002729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Erin
CENTRAL INDEX KEY: 0001754278
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 24597557
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone bio, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Gritstone Oncology, Inc.
DATE OF NAME CHANGE: 20151023
4
1
form4-02062024_120227.xml
X0508
4
2024-02-01
0001656634
Gritstone bio, Inc.
GRTS
0001754278
Jones Erin
C/O GRITSTONE BIO, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
false
true
false
false
EVP, CHIEF OPERATING OFFICER
0
Common Stock
2024-02-01
4
A
0
40000
0
A
324618
D
Stock Option (Right to Buy)
2.46
2024-02-01
4
A
0
235000
0
A
2034-01-31
Common Stock
235000
235000
D
Represents Restricted Stock Units ("RSUs") of which 1/2 vests on the first anniversary of the grant date, with the remainder of grant vesting on the second anniversary of the grant date, subject to the continued service of the Reporting Person on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Includes 271,549 RSUs which are subject to vesting.
The option vests as to 1/24th of the total grant monthly beginning February 1, 2024 until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.
/s/ Vassiliki Economides, Attorney-in-Fact for Erin Jones
2024-02-05